Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

State health officials want to add more facilities for discharged state hospital patients who need support reentering their ...